<DOC>
	<DOCNO>NCT00233649</DOCNO>
	<brief_summary>The purpose study determine DM II patient efficacy Crestor obtain new European LDL cholesterol guideline .</brief_summary>
	<brief_title>DIALOOG : Crestor Patients With Diabetes Mellitus Type 2 : Lowering LDL-C Levels New European Guidelines</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Diabetes Mellitus Type 2 , LDLC &gt; 2,5 mmol/l , cholesterol lower medication use last 3 month , start Crestor 10 mg , permission use patient data AZ</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>